Wasserman R H, Brindak M E, Buddle M M, Cai Q, Davis F C, Fullmer C S, Gilmour R F, Hu C, Mykkanen H M, Tapper D N
Department of Physiology, New York State College of Veterinary Medicine, Cornell University, Ithaca 14853.
Prog Clin Biol Res. 1990;332:99-126.
Vitamin D, with parathyroid hormone and calcitonin, is an essential factor in the homeostatic regulation of systemic calcium in most vertebrate species. Targets for this aspect of vitamin D action, through its biologically active metabolites, are primarily the intestine, kidney and bone. Each of these tissues or organs are stimulated by 1,25(OH)2D3 to increase the transport calcium into the extracellular fluid compartment when plasma calcium levels are below normal and/or when there is a greater need for calcium to meet the requirements of physiological processes, such as growth, gestation and lactation. During such periods, the efficiency of the absorption of calcium from the intestine increases, the resorption of calcium salts from bone is stimulated, and the efficiency of the reabsorption of filtered calcium by the renal tubule is increased. In addition to the homeostatic function of vitamin D, there is an increasing amount of evidence that vitamin D has important effects on tissues and organs other than those concerned with calcium homeostasis. With regard to the intestinal epithelial system, the genomic effect of 1,25(OH)2D3 was shown several years ago when the de novo synthesis of a specific vitamin D-induced calcium-binding protein (CaBP, calbindin-D) was demonstrated. In our view, this appears to be an essential factor in the well-documented enhancement of calcium absorption by vitamin D. The function of calbindin-D, a high affinity calcium-binding protein, in the absorptive process is not precisely known but currently considered to act as an intracellular facilitator of the diffusion of calcium from the microvillar pole of the enterocyte to the basal-lateral membrane. There is evidence that vitamin D influences another step in the absorptive process. This step appears to be associated with the entrance of luminal calcium into the enterocyte, the first step in the transepithelial transport process. This response appears to occur relatively early (1 h or less) after 1,25(OH)2D3 is given to vitamin D-deficient animals, whereas the de novo synthesis of transport proteins has a much longer lag time (about 4 h). The in vitro absorption studies of Nemere et al (1984) and the in vivo experiments of our group (Wasserman et al, 1982) accentuate this point. However, the more rapid reaction, i.e., the possible modification of the permeability properties of the brush border membrane, does not result in a substantive increase in overall calcium absorption unless the enterocyte had been "primed" by previous exposure to vitamin D. The "priming" reaction might represent the synthesis of CaBP or some other intracellular component.(ABSTRACT TRUNCATED AT 400 WORDS)
维生素D与甲状旁腺激素和降钙素一起,是大多数脊椎动物物种全身钙稳态调节的重要因素。维生素D通过其生物活性代谢产物发挥这一作用的靶器官主要是肠道、肾脏和骨骼。当血浆钙水平低于正常水平和/或当有更大的钙需求以满足生理过程(如生长、妊娠和哺乳)的需要时,这些组织或器官中的每一个都会受到1,25(OH)2D3的刺激,以增加钙向细胞外液腔的转运。在这些时期,肠道对钙的吸收效率增加,骨中钙盐的重吸收受到刺激,肾小管对滤过钙的重吸收效率提高。除了维生素D的稳态功能外,越来越多的证据表明维生素D对除与钙稳态相关的组织和器官之外的其他组织和器官也有重要影响。关于肠道上皮系统,几年前就显示了1,25(OH)2D3的基因组效应,当时证明了一种特定的维生素D诱导的钙结合蛋白(CaBP,钙结合蛋白-D)的从头合成。在我们看来,这似乎是维生素D促进钙吸收这一充分记录的现象中的一个重要因素。钙结合蛋白-D是一种高亲和力的钙结合蛋白,其在吸收过程中的功能尚不完全清楚,但目前认为它在细胞内促进钙从肠上皮细胞的微绒毛极扩散到基底外侧膜。有证据表明维生素D影响吸收过程中的另一个步骤。这一步骤似乎与肠腔钙进入肠上皮细胞有关,这是跨上皮转运过程的第一步。在给维生素D缺乏的动物注射1,25(OH)2D3后,这种反应似乎相对较早(1小时或更短时间)出现,而转运蛋白的从头合成有更长的延迟时间(约4小时)。Nemere等人(1984年)的体外吸收研究和我们小组(Wasserman等人,1982年)的体内实验强调了这一点。然而,更快速的反应,即刷状缘膜通透性特性的可能改变,除非肠上皮细胞先前已暴露于维生素D而被“启动”,否则不会导致总体钙吸收的实质性增加。“启动”反应可能代表CaBP或其他一些细胞内成分的合成。(摘要截短至400字)